Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocyte Growth Factor | 6 | 2011 | 13 | 1.480 |
Why?
|
| Intestinal Mucosa | 11 | 2021 | 74 | 1.360 |
Why?
|
| Intestinal Absorption | 6 | 2016 | 21 | 1.220 |
Why?
|
| Short Bowel Syndrome | 4 | 2016 | 13 | 0.980 |
Why?
|
| Adaptation, Physiological | 4 | 2011 | 53 | 0.940 |
Why?
|
| Intestine, Small | 4 | 2016 | 43 | 0.830 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2021 | 897 | 0.580 |
Why?
|
| Ileum | 4 | 2021 | 16 | 0.500 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2016 | 1 | 0.500 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 6 | 0.490 |
Why?
|
| Rats | 12 | 2016 | 1895 | 0.490 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2016 | 68 | 0.470 |
Why?
|
| Apoptosis | 4 | 2021 | 375 | 0.390 |
Why?
|
| Reperfusion Injury | 2 | 2002 | 60 | 0.350 |
Why?
|
| Parenteral Nutrition, Total | 2 | 2010 | 5 | 0.340 |
Why?
|
| Multigene Family | 1 | 2011 | 50 | 0.330 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 478 | 0.330 |
Why?
|
| Colon | 2 | 2019 | 72 | 0.320 |
Why?
|
| Liver Failure | 1 | 2010 | 21 | 0.320 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 140 | 0.320 |
Why?
|
| Animals | 13 | 2021 | 8199 | 0.310 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2021 | 28 | 0.260 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 315 | 0.260 |
Why?
|
| DNA | 4 | 2016 | 223 | 0.240 |
Why?
|
| Glucagon | 1 | 2006 | 5 | 0.240 |
Why?
|
| Jejunum | 1 | 2006 | 8 | 0.240 |
Why?
|
| Galactose | 2 | 2002 | 3 | 0.230 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 23 | 0.220 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 1083 | 0.210 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2002 | 6 | 0.200 |
Why?
|
| Membrane Glycoproteins | 2 | 2002 | 111 | 0.190 |
Why?
|
| Up-Regulation | 3 | 2011 | 193 | 0.190 |
Why?
|
| Cell Proliferation | 2 | 2021 | 603 | 0.190 |
Why?
|
| Premedication | 1 | 2002 | 15 | 0.190 |
Why?
|
| Interleukin-11 | 1 | 2002 | 1 | 0.180 |
Why?
|
| Paneth Cells | 1 | 2021 | 4 | 0.170 |
Why?
|
| Placenta | 1 | 2021 | 74 | 0.160 |
Why?
|
| Female | 9 | 2021 | 19945 | 0.150 |
Why?
|
| Constipation | 1 | 2019 | 12 | 0.150 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 221 | 0.150 |
Why?
|
| Drug Synergism | 1 | 2016 | 66 | 0.120 |
Why?
|
| Wound Healing | 2 | 2021 | 185 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 292 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 160 | 0.110 |
Why?
|
| Infant, Premature, Diseases | 1 | 2014 | 24 | 0.110 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2014 | 38 | 0.100 |
Why?
|
| Male | 8 | 2019 | 19441 | 0.100 |
Why?
|
| Interleukin-6 | 2 | 2010 | 224 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 215 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3416 | 0.090 |
Why?
|
| Hyperplasia | 1 | 2011 | 37 | 0.090 |
Why?
|
| Enterocytes | 1 | 2011 | 7 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2011 | 14 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2011 | 131 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 717 | 0.080 |
Why?
|
| Random Allocation | 2 | 2008 | 247 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 25 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 545 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2011 | 823 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 95 | 0.060 |
Why?
|
| Sodium-Glucose Transporter 1 | 2 | 2002 | 3 | 0.060 |
Why?
|
| Models, Animal | 1 | 2006 | 188 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2005 | 58 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2004 | 28 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 346 | 0.050 |
Why?
|
| Peptides | 1 | 2004 | 127 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2005 | 499 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 99 | 0.050 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2002 | 1 | 0.050 |
Why?
|
| Hexosaminidase A | 1 | 2002 | 1 | 0.050 |
Why?
|
| Glucuronidase | 1 | 2002 | 12 | 0.050 |
Why?
|
| Plasmids | 1 | 2002 | 50 | 0.050 |
Why?
|
| Growth Substances | 1 | 2002 | 9 | 0.050 |
Why?
|
| Glycine | 1 | 2002 | 26 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2002 | 21 | 0.050 |
Why?
|
| Leptin | 1 | 2002 | 61 | 0.040 |
Why?
|
| Transfection | 1 | 2002 | 204 | 0.040 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 12 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 24 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2021 | 136 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 96 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 89 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 237 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2021 | 839 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 961 | 0.030 |
Why?
|
| Inflammation | 1 | 2019 | 506 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 1233 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1534 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2014 | 74 | 0.030 |
Why?
|
| Child | 1 | 2019 | 2435 | 0.020 |
Why?
|
| Humans | 3 | 2021 | 32282 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 666 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1010 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 3519 | 0.020 |
Why?
|
| 1-Naphthylisothiocyanate | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2008 | 3 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2008 | 9 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2008 | 23 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 3626 | 0.020 |
Why?
|
| Liver | 1 | 2008 | 492 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 2004 | 6 | 0.010 |
Why?
|
| Defecation | 1 | 2004 | 6 | 0.010 |
Why?
|
| HLA-B27 Antigen | 1 | 2004 | 7 | 0.010 |
Why?
|
| Glucagon-Like Peptides | 1 | 2004 | 16 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 99 | 0.010 |
Why?
|
| Diarrhea | 1 | 2004 | 56 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 151 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 471 | 0.010 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 97 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 186 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 160 | 0.010 |
Why?
|